NGNE

Neurogene Inc.

Healthcare · Biotechnology

$99.74 sample

-1.09 (-1.08%) 1D

Market cap

$181.6B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-13

Alerts

8

Price$99.74 -7.55% 3M daily closessample

108.9999.74

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13SEC10-Q filed
Oct 02INSInsider buy: 10% owner
Sep 23INSInsider buy: Director
Sep 16SEC8-K filed: material event
Sep 08INSInsider sell: EVP, Operations
Sep 02SECForm 144 filed
Aug 27INSInsider buy: Chief Financial Officer
Aug 20INSInsider buy: EVP, Operations

Sign up to see the real NGNE record →

Company facts

SEC EDGAR registration

Name: Neurogene Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +28sample, -100 to +100
Reporting currency: USD

Who is positioning in NGNE

sample

Insiders: 6 insider transactions over 90 days, net selling, $121.7M
Congress: 1 members traded over 90 days
Institutions · 13F: 16 funds hold $1.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$11.7B +14.7% y/y

Q4 2024Q3 2026

Inventory$7.1B +20.2% y/y

Q4 2024Q3 2026

Accounts receivable$5.1B +8.1% y/y

Q4 2024Q3 2026

Total debt$13.7B +13.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $123.6B -10.4% 3M
Sample peer B: $141.2B +6.6% 3M
Sample peer C: $122.9B -7.9% 3M
Sample peer D: $78.1B +9.3% 3M
Sample peer E: $33.2B +12.9% 3M